Inherited Retinal Diseases

Latest News

Nanoscope Therapeutics publishes clinical data on vision restoration in retinitis pigmentosa
Nanoscope Therapeutics publishes clinical data on vision restoration in retinitis pigmentosa

March 26th 2025

Administered via intravitreal injection, Synthopsin-MCO-010 possesses a promoter to specifically target ON-bipolar cells.

First patient dosed in Phase 1/2 ASTRA study for Stargardt disease therapy SB-007 (SpliceBio)
First patient dosed in Phase 1/2 ASTRA study for Stargardt disease therapy SB-007 (SpliceBio)

March 15th 2025

FDA approves revakinagene taroretcel-lwey (ENCELTO) for macular telangiectasia type 2
FDA approves revakinagene taroretcel-lwey (ENCELTO) for macular telangiectasia type 2

March 6th 2025

EMA provides positive ATMP opinion for gene therapy products OCU410 and OCU410ST
EMA provides positive ATMP opinion for gene therapy products OCU410 and OCU410ST

March 5th 2025

Study demonstrates visual acuity improvements following gene therapy for AIPL1-associated inherited retinal dystrophies
Study demonstrates visual acuity improvements following gene therapy for AIPL1-associated inherited retinal dystrophies

February 28th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.